{
    "nct_id": "NCT05366413",
    "official_title": "Pilot Study of Early Referral to Interventional Pain Management for Patients With Advanced Malignancies",
    "inclusion_criteria": "* Diagnosis of a metastatic, or locally advanced unresectable malignancy\n* Anticipated prognosis of more than 6 months according to the primary oncologist\n* Age greater than 21 years\n* Persistent pain with an average pain rating of 4 or greater on an 11-point numeric rating scale (NRS) from 0-10 where 10 is considered the most severe.\n* Pain has persisted for at least 2 weeks\n* Pain is due to cancer or sequelae of cancer treatment\nHealthy volunteers allowed\nMust have minimum age of 21 Years",
    "exclusion_criteria": "* Primary pain syndrome is sensory peripheral neuropathy\n* Patient is taking more than 200 morphine milligram equivalents (MMEs) per day on average, at the time of recruitment.\n* Currently cared for by interventional pain management specialist\n* Receipt of prior pain intervention (e.g. celiac neurolysis)\n* Bleeding diathesis, uncontrollable infection, or other contra-indications to pain interventions\n* History of opioid misuse disorder\n* Inability to speak English\n* Cognitive impairment or any other disorder that would impede study participation and survey completion\n* If patients are unable to complete the baseline survey, they will no longer be considered eligible for the study; this will serve as an indication of barriers to participation that would make them unable to comply with study procedures.",
    "miscellaneous_criteria": ""
}